Kebbi is a state located in the northwestern region of Nigeria. Working in partnership for years, the Nigerian Federal Ministry of Health, Sightsavers, and
Progress in eliminating onchocerciasis in the WHO Region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to
Authors: Elizabeth Fitch, Alison Krentel, Kevin Bardosh, Beth Sutherland, Alyssa Jordan, and Margaret Baker The World Health Organization’s 2021-2030 NTD Road Map advocates for
Onchocerciasis: diagnostic target product profile to support preventive chemotherapy. WHO, 2021. Overview Onchocerciasis, also known as river blindness, affects an estimated 21 million people,
Video recordings from “The Power of Partnership: Defeating Onchocerciasis” symposium are ready to view. Featuring 29 speakers from diverse aspects of the campaign, the
This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in
Progress report on the elimination of human onchocerciasis, 2018–2019. Weekly Epidemiological Record. WHO, 2019. Overview November 8, 2019 Onchocerciasis is a parasitic infection caused
Progress report on the elimination of human onchocerciasis, 2017–2018. Weekly Epidemiological Record. WHO, 2018 Overview Onchocerciasis, commonly known as “river blindness”, is a parasitic
On June 14, 2018, the US FDA approved moxidectin as a treatment for onchocerciasis (river blindness). We applaud Medicines Development for Global Health (MDGH)
Article on the importance of cross-border issues in onchocerciasis elimination programmes. Bush, Sodahlon, Downs and Mackenzie, International Health, Volume 10, Issue suppl_1, 1 March 2018,
Article on the use of alternative (or complementary) treatment strategies (ATSs) to accelerate the elimination of onchocerciasis. Boussinesq et al., International Health, Volume 10,
Article on eliminating onchocercias as a public health problem in Uganda. Katabarwa et al, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages
A review summarizing the progress made in identifying diagnostics that meet the specialized requirements needed to verify onchocerciasis elimination, as well as a discussion
Article on the acquisition of quality-assured (QA) data that ultimately define the absence of infection or transmission of onchocerciasis in previously endemic areas in Africa. International
